NeuBase Therapeutics, Inc. - stock earnings
NBSE Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q3 | -1.8 million USD | ? USD |
| 2023Q2 | -3.4 million USD | ? USD |
| 2023Q1 | -4.0 million USD | ? USD |
| 2022Q4 | -5.0 million USD | ? USD |
| 2022Q3 | -7.5 million USD | ? USD |
| 2022Q2 | -8.6 million USD | ? USD |
| 2022Q1 | -9.9 million USD | ? USD |
| 2021Q4 | -7.7 million USD | ? USD |
| 2021Q3 | -7.2 million USD | ? USD |
| 2021Q2 | -8.7 million USD | ? USD |
| 2021Q1 | -5.5 million USD | ? USD |
| 2020Q4 | -4.1 million USD | ? USD |
| 2020Q3 | -4.7 million USD | ? USD |
| 2020Q2 | -3.8 million USD | ? USD |
| 2020Q1 | -4.4 million USD | ? USD |
| 2019Q4 | -23.8 million USD | ? USD |
| 2019Q3 | -23.8 million USD | ? USD |
| 2019Q2 | -1.1 million USD | ? USD |
| 2019Q1 | -1.1 million USD | ? USD |
| 2018Q4 | -6.4 million USD | ? USD |
| 2018Q3 | -6.4 million USD | ? USD |
| 2018Q2 | -545028 USD | ? USD |
| 2018Q1 | -2.2 million USD | ? USD |
| 2017Q4 | -4.2 million USD | ? USD |
| 2017Q3 | -5.2 million USD | -32272 USD |
| 2017Q2 | -3.9 million USD | ? USD |
| 2017Q1 | -7.7 million USD | ? USD |
| 2016Q4 | -7.0 million USD | ? USD |
| 2016Q3 | -6.6 million USD | 739 USD |
| 2016Q2 | -7.7 million USD | ? USD |
| 2016Q1 | -5.3 million USD | ? USD |
| 2015Q4 | -6.1 million USD | ? USD |
| 2015Q3 | -3.9 million USD | ? USD |
| 2015Q2 | -3.3 million USD | ? USD |
| 2015Q1 | -3.4 million USD | ? USD |
| 2014Q4 | -4.6 million USD | ? USD |
| 2014Q3 | -3.1 million USD | ? USD |
| 2014Q2 | -2.1 million USD | ? USD |
| 2014Q1 | -2.0 million USD | ? USD |
| 2013Q4 | -2.0 million USD | ? USD |
| 2013Q3 | -1.8 million USD | ? USD |
| 2013Q2 | -1.3 million USD | ? USD |
| 2013Q1 | -292258 USD | ? USD |
| 2012Q4 | 67449 USD | ? USD |
| 2012Q3 | 67449 USD | ? USD |
| 2012Q2 | -460753 USD | ? USD |
| 2012Q1 | -1.4 million USD | ? USD |
| 2011Q4 | -1.4 million USD | ? USD |
| 2011Q3 | -1.4 million USD | ? USD |
| 2011Q2 | -3.1 million USD | ? USD |
| 2011Q1 | -156918 USD | ? USD |
| 2010Q4 | 3.9 million USD | ? USD |
| 2010Q3 | 3.9 million USD | ? USD |
| 2010Q2 | -176605 USD | ? USD |
| 2010Q1 | -3.0 million USD | ? USD |
| 2009Q4 | -127449 USD | ? USD |
| 2009Q3 | -127449 USD | ? USD |
| 2009Q2 | -229000 USD | ? USD |
| 2009Q1 | -444000 USD | ? USD |
| 2008Q4 | -281000 USD | -630000 USD |
| 2008Q3 | -281000 USD | ? USD |
| 2008Q2 | 11000 USD | ? USD |
| 2008Q1 | -92000 USD | ? USD |
| 2007Q4 | -192000 USD | 2000 USD |
| 2007Q3 | -192000 USD | 2000 USD |
| 2007Q2 | -3.2 million USD | 10000 USD |
| 2007Q1 | -1.6 million USD | 130000 USD |
| 2006Q4 | -50265 USD | ? USD |
| 2006Q3 | -9116 USD | ? USD |
| 2006Q2 | 78852 USD | ? USD |
| 2006Q1 | 44266 USD | 1.9 million USD |
| 2005Q4 | -40528 USD | 1.7 million USD |
| 2005Q3 | 83433 USD | 1.9 million USD |
| 2005Q2 | -30553 USD | 1.8 million USD |
| 2005Q1 | 63455 USD | 1.7 million USD |
| 2004Q4 | 77427 USD | 1.6 million USD |
| 2004Q3 | 49630 USD | 1.4 million USD |
| 2004Q2 | 92580 USD | 1.4 million USD |
| 2004Q1 | 65386 USD | 1.3 million USD |
NBSE Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2022 | -34.2 million USD | ? USD |
| 2021 | -25.7 million USD | ? USD |
| 2020 | -17.3 million USD | ? USD |
| 2019 | -27.1 million USD | ? USD |
| 2018 | -13.2 million USD | ? USD |
| 2017 | -23.8 million USD | ? USD |
| 2016 | -25.8 million USD | ? USD |
| 2015 | -15.2 million USD | ? USD |
| 2014 | -9.1 million USD | ? USD |
| 2013 | -5.7 million USD | ? USD |
| 2012 | -1.5 million USD | ? USD |
| 2011 | -5.1 million USD | ? USD |
| 2010 | 494377 USD | ? USD |
| 2009 | -864449 USD | ? USD |
| 2008 | 25000 USD | ? USD |
| 2007 | -6.3 million USD | 389000 USD |
| 2006 | -4.7 million USD | 120000 USD |
| 2005 | 75862 USD | 7.2 million USD |
| 2004 | 285028 USD | 5.7 million USD |
| 2003 | 101851 USD | 3.8 million USD |
NBSE
Price: $0.40
52 week price:
Earnings Per Share: -18.60 USD
P/E Ratio: -0.04
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 97523
Market Capitalization: 1.5 million